Exhibit & Meeting Guide
Download final Exhibit & Meeting Guide here. (PDF)
Supporter Manual (PDF format)
IMPORTANT UPDATE! As of April 23, 2014 the ACCME has modified its requirements to prohibit the use of ACCME-defined commercial interest logos in disclosure of commercial support. The changes include modifications to Standards for Commercial Support: Standards to Ensure Independence in CME Activities and are effective immediately.
The 2014 Joint ACTRIMS-ECTRIMS Industry Support Prospectus has been updated to reflect such regulations. Industry supporters are encouraged to review the complete policy; however, important highlights are outlined below.
- Standard 4.3: Educational materials that are part of a CME activity, such as slides, abstracts and handouts, cannot contain any advertising, corporate logo, trade name or a product-group message of an ACCME-defined commercial interest.
- Standard 6.3: The source of all support from commercial interests must be disclosed to learners. When commercial support is "in-kind‟ the nature of the support must be disclosed to learners.
- Standard 6.4: Disclosure must never include the use of a corporate logo, trade name or a product-group message of an ACCME-defined commercial interest.
Access the Support Prospectus
Download the Support Prospectus (PDF format)
Download the Exhibition & Meeting Guide Ad Rates (PDF format)
ABOUT THE JOINT MEETING
2014 marks the sixth triennial meeting of ACTRIMS and ECTRIMS. The Joint Meeting is expected to be the largest single gathering of MS scientists, researchers, medical doctors and health care professionals who work to advance treatment and research in multiple sclerosis. Held in the John B. Hynes Veterans Memorial Convention Center in Boston, Massachusetts, USA, 10-13 September 2014, it brings together a global audience of over 6,000 attendees from over ninety countries.